Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study

BACKGROUND: Comparative data on mortality in COVID-19 patients treated with molnupiravir or with nirmatrelvir plus ritonavir are inconclusive. We therefore compared all-cause mortality in community-dwelling COVID-19 patients treated with these drugs during the Omicron era. METHODS: Data collected in...

Descripción completa

Detalles Bibliográficos
Autores principales: Torti, Carlo, Olimpieri, Pier Paolo, Bonfanti, Paolo, Tascini, Carlo, Celant, Simone, Tacconi, Danilo, Nicastri, Emanuele, Tacconelli, Evelina, Cacopardo, Bruno, Perrella, Alessandro, Buccoliero, Giovanni Battista, Parruti, Giustino, Bassetti, Matteo, Biagetti, Carlo, Giacometti, Andrea, Erne, Elke Maria, Frontuto, Maria, Lanzafame, Massimiliano, Summa, Valentina, Spagnoli, Alessandra, Vestri, Annarita, Di Perri, Giovanni, Russo, Pierluigi, Palù, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398591/
https://www.ncbi.nlm.nih.gov/pubmed/37547273
http://dx.doi.org/10.1016/j.lanepe.2023.100684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398591/
https://www.ncbi.nlm.nih.gov/pubmed/37547273
http://dx.doi.org/10.1016/j.lanepe.2023.100684

Ejemplares similares